πŸ‡ΊπŸ‡Έ FDA
Patent

US 10125112

Modulators of the relaxin receptor 1

granted A61PA61P9/00

Quick answer

US patent 10125112 (Modulators of the relaxin receptor 1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P9/00